# Roche Expects FDA Decision on Experimental Breast Cancer Pill by Dec. 18 - Date: 2026-04-23 - Category: Biotech & Life Sciences In roughly 60 days, the FDA will decide whether to approve a breast cancer drug that failed its most scrutinized clinical trial. The data that matters most hasn't been released yet. ---